Review: taking Lamictal and Remeron together


Summary

Drug interactions are reported among people who take Lamictal and Remeron together. This review analyzes the effectiveness and drug interactions between Lamictal and Remeron. It is created by eHealthMe based on reports of 930 people who take the same drugs from FDA and social media, and is updated regularly.

You are not alone

Join a support group for people who take Lamictal and Remeron >>>

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA and social media since 1977. Our tools are free and anonymous. 86 million people have used us. 300+ peer-reviewed medical journals have referenced our original studies. Start now >>>


Lamictal

Lamictal has active ingredients of lamotrigine. It is often used in bipolar disorder. (latest outcomes from Lamictal 40,259 users)

Remeron

Remeron has active ingredients of mirtazapine. It is often used in depression. (latest outcomes from Remeron 12,730 users)

On Jul, 27, 2016

930 people who take Lamictal, Remeron are studied.


Number of reports submitted per year:

Lamictal and Remeron drug interactions.

Drug effectiveness over time:

Lamictal:
  • < 1 month: 0.0% - (0 of 5 people)
  • 1 - 6 months: 28.0% - (6 of 21 people)
  • 6 - 12 months: 12.0% - (4 of 32 people)
  • 1 - 2 years: 50.0% - (11 of 22 people)
  • 2 - 5 years: 60.0% - (9 of 15 people)
  • 5 - 10 years: 44.0% - (4 of 9 people)
  • 10+ years: 0.0% - (0 of 1 people)
  • not specified: 0.0% - (0 of 1 people)
Remeron:
  • < 1 month: 0.0% - (0 of 4 people)
  • 1 - 6 months: 40.0% - (11 of 27 people)
  • 6 - 12 months: 36.0% - (4 of 11 people)
  • 1 - 2 years: 36.0% - (8 of 22 people)
  • 2 - 5 years: 54.0% - (6 of 11 people)
  • 5 - 10 years: 66.0% - (2 of 3 people)
  • 10+ years: 50.0% - (1 of 2 people)
  • not specified: 0.0% - (0 of 0 people)

Drug effectiveness by gender:

Lamictal:
  • female: 34.0% - (27 of 78 people)
  • male: 25.0% - (7 of 28 people)
Remeron:
  • female: 44.0% - (24 of 54 people)
  • male: 30.0% - (8 of 26 people)

Drug effectiveness by age:

Lamictal:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 0.0% - (0 of 23 people)
  • 20-29: 47.0% - (9 of 19 people)
  • 30-39: 55.0% - (15 of 27 people)
  • 40-49: 30.0% - (3 of 10 people)
  • 50-59: 7.0% - (1 of 13 people)
  • 60+: 42.0% - (6 of 14 people)
Remeron:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 100.0% - (1 of 1 people)
  • 20-29: 38.0% - (7 of 18 people)
  • 30-39: 46.0% - (12 of 26 people)
  • 40-49: 66.0% - (6 of 9 people)
  • 50-59: 25.0% - (3 of 12 people)
  • 60+: 21.0% - (3 of 14 people)

Most common drug interactions over time *:

< 1 month:
  • rash
  • stevens-johnson syndrome
  • dehydration
  • pyrexia
  • suicide attempt
  • abnormal behaviour
  • aspartate aminotransferase increased
  • epilepsy
  • pruritus
  • alanine aminotransferase increased
1 - 6 months:
  • chills
  • pyrexia
  • rash
  • dry skin
  • aches and pains in bones
  • bowel movement irregularity
  • dry mouth
  • dry throat
  • hot flashes
  • muscle aches
6 - 12 months:
  • exhaustion, fatigue, lethargy, tiredness, weariness
  • suicidal ideation
  • abdominal pain lower
  • anxiety, apprehension, feeling uptight, jitters, stress, stress and anxiety, tension
  • arthritis - neck
  • back pain - low
  • blind
  • blurred vision
  • crying
  • depression - chronic
1 - 2 years:
  • agoraphobia
  • anxiety disorder
  • crying - excessive (0-6 months)
  • depressed mood
  • diarrhoea aggravated
  • tooth loss
  • attention deficit/hyperactivity disorder
  • bipolar 1
  • diabetes
  • generalised anxiety disorder
2 - 5 years:
  • jaundice
  • leukopenia
  • body temperature increased
  • respiratory failure
  • septic shock
  • pneumonia streptococcal
  • blood bilirubin increased
  • suicidal ideation
  • weight gain - unintentional
  • alanine aminotransferase increased
5 - 10 years:
  • bronchitis
  • chronic lymphocytic leukaemia
  • diabetes insipidus
  • diabetes mellitus
  • glucose tolerance impaired
  • lung infection
  • convulsion
  • pancytopenia
  • general physical health deterioration
  • ankylosing spondylitis
10+ years:
  • abnormal behaviour
  • anxiety
  • completed suicide
  • depression
  • insomnia
  • tooth loss
not specified:
  • diabetes mellitus
  • type 2 diabetes mellitus
  • rash
  • nausea
  • weight increased
  • convulsion
  • depression
  • anxiety
  • dizziness
  • insomnia

Most common drug interactions by gender *:

female:
  • rash
  • diabetes mellitus
  • anxiety
  • type 2 diabetes mellitus
  • convulsion
  • oedema peripheral
  • pyrexia
  • white blood cell count decreased
  • ataxia
  • dizziness
male:
  • weight increased
  • type 2 diabetes mellitus
  • diabetes mellitus
  • nausea
  • insomnia
  • rash
  • depression
  • pain
  • fatigue
  • drug ineffective

Most common drug interactions by age *:

0-1:
  • blood cholesterol increased
  • blood triglycerides increased
  • diabetes mellitus
  • hyperlipidaemia
  • neuroleptic malignant syndrome
  • ovarian cyst
2-9:
  • aggression
  • blood chloride decreased
  • electroencephalogram abnormal
  • eosinophilia
  • inappropriate antidiuretic hormone secretion
  • leukocytosis
  • mental impairment
  • neutropenia
  • neutrophilia
  • syncope
10-19:
  • exhaustion, fatigue, lethargy, tiredness, weariness
  • suicide attempt
  • rash
  • agitation
  • depression
  • disturbance in attention
  • drug ineffective
  • headache
  • pyrexia
  • somnolence
20-29:
  • pancreatitis acute
  • intentional overdose
  • ataxia
  • metabolic acidosis
  • nystagmus
  • lethargy
  • tachycardia
  • intentional self-injury
  • altered state of consciousness
  • dysarthria
30-39:
  • rash
  • type 2 diabetes mellitus
  • nausea
  • weight increased
  • insomnia
  • diabetes mellitus
  • weight decreased
  • blood cholesterol increased
  • tachycardia
  • mental impairment
40-49:
  • type 2 diabetes mellitus
  • septic shock
  • diabetes mellitus
  • convulsion
  • neuropathy peripheral
  • cardiac arrest
  • depression
  • rash
  • febrile neutropenia
  • blood glucose increased
50-59:
  • diabetes mellitus
  • oedema peripheral
  • white blood cell count decreased
  • gastrointestinal carcinoma
  • haemorrhage
  • type 2 diabetes mellitus
  • dizziness
  • weight increased
  • nausea
  • pyrexia
60+:
  • stevens-johnson syndrome
  • leukopenia
  • rash
  • tremor
  • neutropenia
  • dehydration
  • body temperature increased
  • jaundice
  • pneumonia
  • loss of consciousness

* Approximation only. Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Do you take Lamictal and Remeron?

Can you answer these questions?

More questions for: Lamictal, Remeron

You may be interested in these reviews

More reviews for: Lamictal, Remeron

On eHealthMe, Lamictal (lamotrigine) is often used to treat bipolar disorder. Remeron (mirtazapine) is often used to treat depression. Find out below the conditions the drugs are used for and how effective they are.

What is the drug used for and how effecitve is it:


NOTE: The study is based on active ingredients and brand name. Other drugs that have the same active ingredients (e.g. generic drugs) are NOT considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.